Delays like this spells trouble.It happened with ADX and only the people close to the director got out before the announcement. Then wallop - the Ann and then 75% drop in sp.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%